Turner, Bruce <br/><br/>
Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.  [electronic resource] 

 -  Urologic nursing   
 - 111-6, 154 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1053-816X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Angiogenesis Inhibitors--therapeutic use<br/>Bisphosphonate-Associated Osteonecrosis of the Jaw--epidemiology<br/>Bone Density Conservation Agents--adverse effects<br/>Bone Neoplasms--drug therapy<br/>Denosumab--adverse effects<br/>Diphosphonates--adverse effects<br/>Humans<br/>Imidazoles--adverse effects<br/>Immunosuppressive Agents--therapeutic use<br/>Incidence<br/>Jaw Diseases--chemically induced<br/>Male<br/>Osteonecrosis--chemically induced<br/>Prostatic Neoplasms--pathology<br/>Risk Factors<br/>Stomatognathic Diseases--epidemiology<br/>Tooth Extraction--statistics & numerical data<br/>United Kingdom--epidemiology<br/>Zoledronic Acid